This course has expired. View available courses.
Oncology, Public Health
Metastatic Castration-Resistant Prostate Cancer: Optimizing Patient-Centric Management – Ordre des pharmaciens du Québec (OPQ)
DURATION
PROFESSION
# OF CREDITS
1
ACCREDITATION
EXPIRY DATE
2018-04-27
Learning objectives
By the end of this course, the participant will be able to:
- Discuss the role of specialists, family physicians and pharmacists and the importance of communication between healthcare professionals in the optimal, patient-centric management of prostate cancer
- Describe the role of Androgen Receptor Axis-Targeted (ARAT) agents in treating metastatic castration resistant prostate cancer (mCRPC) and know which ARAT agents are available in Canada
- Identify and manage the dose-adjustments, drug-drug interactions and adverse effects of ARAT agents abiraterone acetate and enzalutamide
- Describe the most appropriate treatment options for different patient profiles and effectively counsel patients regarding their treatment options, adverse effects and the importance of adherence